NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · IEX Real-Time Price · USD
1.190
+0.080 (7.21%)
At close: Jul 19, 2024, 4:00 PM
1.150
-0.040 (-3.36%)
Pre-market: Jul 22, 2024, 7:52 AM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $30.67 million as of July 22, 2024. Its market cap has decreased by -86.19% in one year.
Market Cap
30.67M
Enterprise Value
52.60M
1-Year Change
-86.19%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since May 21, 2021, NKGen Biotech's market cap has decreased from $186.20M to $30.67M, a decrease of -83.53%. That is a compound annual growth rate of -43.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 29.60M | -50.83% |
| Dec 29, 2023 | 60.20M | -71.79% |
| Dec 30, 2022 | 213.40M | 2.65% |
| Dec 31, 2021 | 207.90M | 11.65% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 31.59M |
| Reviva Pharmaceuticals Holdings | 31.31M |
| VYNE Therapeutics | 30.95M |
| SeaStar Medical Holding | 30.73M |
| Equillium | 30.67M |
| MiNK Therapeutics | 30.56M |
| CareCloud | 30.51M |
| Spectral AI | 30.42M |